| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/20/2005 | EP1554382A1 Gpr54 knock-out mammals and screening methods using them |
| 07/20/2005 | EP1554381A2 Post transcriptional silencing by short interfering rnas |
| 07/20/2005 | EP1554375A2 Adenovirus expressing genes in reverse order and use thereof |
| 07/20/2005 | EP1553983A2 New settings for recombinant adenoviral-based vaccines |
| 07/20/2005 | EP1553973A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 07/20/2005 | EP1553966A2 Human papillomavirus polypeptides and immunogenic compositions |
| 07/20/2005 | EP1553960A1 Neuregulin based methods and compositions for treating cardiovascular diseases |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1553833A2 Cardiac muscle regeneration using mesenchymal stem cells |
| 07/20/2005 | EP1241254B1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 07/20/2005 | EP1198570B1 Monomeric protein of the tgf-beta family |
| 07/20/2005 | EP1180243B1 Uses of notch related genes |
| 07/20/2005 | EP1169052B1 Vegf angiogenic growth factors for treatment of peripheral neuropathy |
| 07/20/2005 | EP1121137B1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 07/20/2005 | EP1005538B1 Potassium channel proteins for use in gene therapy for alleviating erectile dysfunction |
| 07/20/2005 | EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 07/20/2005 | CN1643380A Use of the MAL protein as a tumour marker |
| 07/20/2005 | CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system |
| 07/20/2005 | CN1643149A Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 07/20/2005 | CN1643147A Methods and means for monitoring and modulating gene silencing |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642968A A human ribonucleotide reductase M2 subunit |
| 07/20/2005 | CN1642967A Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
| 07/20/2005 | CN1642579A Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642560A Hyaluronic acid mediated adenoviral transduction |
| 07/20/2005 | CN1641035A Plasmid of recombinant immunotoxin IP 10-DT 390 aimed at activating Th1 cell, and its preparing method and use |
| 07/20/2005 | CN1641023A Plasmid of recombinant immunotoxin Rantes-DT390 aimed at activating Th1 cell, and its preparing method and use |
| 07/20/2005 | CN1640497A Swing breeding and respiratory syndrome suicide DNA vaccine and use |
| 07/20/2005 | CN1640496A Recombinant adenovirus lyophilized preparation and its preparing method |
| 07/20/2005 | CN1640494A Method for preparing avian polyvalent nucleic acid vaccine containing multiple virus antigen epitope |
| 07/20/2005 | CN1211486C A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 07/20/2005 | CN1211126C Vascular endothelial growth factor 2 |
| 07/19/2005 | US6919439 Derivatized oligonucleotides having improved uptake and other properties |
| 07/19/2005 | US6919438 Comprises viral expression vector coding envelope protein domains for use as gene therapeutic tool in the treatment of autoimmune diseases |
| 07/19/2005 | US6919433 Antibodies to protein HPMBQ91 |
| 07/19/2005 | US6919432 Substances and their uses |
| 07/19/2005 | US6919318 Enhancing immune responses to genetic immunization by using a chemokine |
| 07/19/2005 | US6919309 Methods and compositions for inhibiting angiogenesis |
| 07/19/2005 | US6919208 Methods and compositions for enhancing the delivery of a nucleic acid to a cell |
| 07/19/2005 | US6919207 Noninvasive; gene therapy; introducing electromagnetic field response elements into a gene promoter to serve as switches for regulating exogenously introduced genes; and applying electromagnetic field to induce gene expression. |
| 07/19/2005 | US6919206 Medium containing flt3 ligand for culturing hematophoietic cells |
| 07/19/2005 | US6919185 An isolated polynucleotide encoding the enzyme polypeptide, genetic engineering, diagnostic kit, drug screening, antibodies; theraptic treatment of cancer, anemia, and end-stage renal disease |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063303A1 Use of human cord blood-derived pluripotent cells for the treatment of disease |
| 07/14/2005 | WO2005063302A1 Drug for preventing or treating heart diseases comprising cd9 gene |
| 07/14/2005 | WO2005063220A1 Modulation of 5-ht2 receptors as a treatment for cardiovascular diseases |
| 07/14/2005 | WO2005062995A2 INHIBITION OF CALCIUM-INDEPENDENT PHOSPHOLIPASES A2β OR A2Ϝ INHIBIT HORMONE-INDUCED DIFFERENTIATION OF 3T3-L1 PREADIPOCYTES |
| 07/14/2005 | WO2005062957A2 Compositions and methods for combined therapy of disease |
| 07/14/2005 | WO2005062942A2 Novel oligonucleotides and treating cardiac disorders by using the same |
| 07/14/2005 | WO2005062890A2 Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel |
| 07/14/2005 | WO2005062881A2 Gene therapy using transposon-based vectors |
| 07/14/2005 | WO2005062767A2 Hoxd3, hoxa3, and hoxb3 compositions and methods for improved wound healing |
| 07/14/2005 | WO2005051351A3 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification |
| 07/14/2005 | WO2005047519A3 Lsamp and nore 1 down-regulation in clear cell renal cell carcinomas |
| 07/14/2005 | WO2005046612A3 Hydroxy piperidine derivatives to treat gaucher disease |
| 07/14/2005 | WO2005035779A3 Method |
| 07/14/2005 | WO2005023990A3 Trans-splicing mediated photodynamic therapy |
| 07/14/2005 | WO2005021583A3 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β |
| 07/14/2005 | WO2005016274A3 Rnai treatment of eye disease |
| 07/14/2005 | WO2005010149A3 Subgroup b adenoviral vectors for treating disease |
| 07/14/2005 | WO2004020969A3 Production of nanoparticles having a defined number of ligands |
| 07/14/2005 | WO2003082212A3 Method for treating cancer in humans |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050154193 Immunoglobulin for use in diagnosis, prevention and treatment of infection, neurodegenerative, inflammatory and autoimmune disorders; immunotherapy |
| 07/14/2005 | US20050154187 Especially fused to dihydrofolate reductase, used for treating diseases marked by increased angiogenesis; also polynucleotides encoding the polypeptide and use of the polynucleotides in gene therapy. |
| 07/14/2005 | US20050154165 Ph-sensitive polymer |
| 07/14/2005 | US20050153935 Compound and method for treating androgen-independent prostate cancer |
| 07/14/2005 | US20050153927 Gene expression inhibition; drug screening; peroxisome proliferator-activated receptor agonists such as fenofibrate |
| 07/14/2005 | US20050153925 Compositions and their uses directed to transferases |
| 07/14/2005 | US20050153924 Antisense modulation of interferon gamma receptor 2 |
| 07/14/2005 | US20050153923 Receptor protein kinases (EphA2/EphA4); gene expression inhibition; rna interference; for treatment, management, or prevention of hyperproliferative cell disease/cancer |
| 07/14/2005 | US20050153919 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 07/14/2005 | US20050153918 Purified short interference RNA; for neoplastic treatment; kits |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153913 Nucleic acid carrier compositions and methods for their synthesis |
| 07/14/2005 | US20050153912 Antiviral oligonucleotides targeting viral families |
| 07/14/2005 | US20050153909 Producing a cell that contains heterologous nucleic acid byintroducing a satellite artificial chromosome (SATAC) into the cell |
| 07/14/2005 | US20050153906 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin, optionally in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy |
| 07/14/2005 | US20050153891 proteins coded by murine herpes viruses, or homologues, use in binding chemokines, to produce an immunomodulatory or antiinflammatory effects |
| 07/14/2005 | US20050153890 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2005 | US20050153887 Compositions for inducing cell growth and differentiation and methods of using same |
| 07/14/2005 | US20050153886 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 07/14/2005 | US20050153878 Fgfr agonists |
| 07/14/2005 | US20050153871 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow |
| 07/14/2005 | US20050153451 Intravascular delivery of non-viral nucleic acid |
| 07/14/2005 | US20050153442 Adipose-derived stem cells and lattices |
| 07/14/2005 | US20050153441 Adipose-derived stem cells and lattices |
| 07/14/2005 | US20050153337 iRNA conjugates |
| 07/14/2005 | US20050153336 Antisense oligonucleotide sequences for use in controlling expression from single transducers and activators of transcription gene (STAT) and treating cell proliferative disorders |
| 07/14/2005 | US20050153335 Expression vector comprising nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatmment of cell proliferative, inflammatory and nervous system disorders |
| 07/14/2005 | US20050153332 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 07/14/2005 | US20050153331 Expression vector comprising nucleotide sequences coding sialic acid synthetase and/or aldolase for use in prevention and treatment of cell proliferative, immunological and muscular disorders |
| 07/14/2005 | US20050153305 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050153281 Incubating a cell containing an HCV RNA having a heterologous polynucleotide with a sequence encoding a transactivator; the cell has a transactivated coding region with an operator sequence linked to it that encodes a detectable marker; transactivator alters transcription of the coding region |
| 07/14/2005 | US20050152959 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell |
| 07/14/2005 | US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis |
| 07/14/2005 | US20050152920 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 07/14/2005 | US20050152917 Fusion protein for use in the treatment of viral diseases |